AI vs doctors: which finds breast cancer risk better?
NCT ID NCT05968157
Summary
This study is testing whether a new artificial intelligence (AI) tool called Mirai can better identify women at high risk for breast cancer compared to current standard methods. Researchers will invite about 200 women identified as high-risk by either method to receive an MRI scan to look for cancer. The goal is to see if the AI tool helps find more cancers earlier and works fairly for women of all races and ethnicities.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UMass Medical School
RECRUITINGWorcester, Massachusetts, 01655, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.